Atomistry » Fluorine » PDB 4ymq-4zg9 » 4ytf
Atomistry »
  Fluorine »
    PDB 4ymq-4zg9 »
      4ytf »

Fluorine in PDB 4ytf: Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases

Enzymatic activity of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases

All present enzymatic activity of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases:
2.7.10.2;

Protein crystallography data

The structure of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases, PDB code: 4ytf was solved by L.Farmer, M.W.Ledeboer, H.J.Zuccola, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.41 / 1.78
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 94.012, 102.068, 67.795, 90.00, 90.00, 90.00
R / Rfree (%) 18.3 / 21.3

Other elements in 4ytf:

The structure of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases (pdb code 4ytf). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases, PDB code: 4ytf:
Jump to Fluorine binding site number: 1; 2; 3; 4;

Fluorine binding site 1 out of 4 in 4ytf

Go back to Fluorine Binding Sites List in 4ytf
Fluorine binding site 1 out of 4 in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F4000

b:29.7
occ:1.00
 F3 A:4HZ4000 0.0 29.7 1.0
C6 A:4HZ4000 1.3 25.9 1.0
C7 A:4HZ4000 2.3 25.0 1.0
C5 A:4HZ4000 2.4 23.3 1.0
N1 A:4HZ4000 2.8 23.6 1.0
O A:HOH4209 3.0 37.9 1.0
O A:HOH4156 3.1 40.2 1.0
O A:LEU855 3.3 31.4 1.0
O A:HOH4120 3.4 22.7 1.0
O A:HOH4122 3.5 33.9 1.0
N2 A:4HZ4000 3.6 23.8 1.0
N3 A:4HZ4000 3.7 19.7 1.0
CA A:GLY856 3.8 28.8 1.0
C8 A:4HZ4000 4.1 20.5 1.0
C A:LEU855 4.1 31.1 1.0
C1 A:4HZ4000 4.3 25.6 1.0
N A:GLY856 4.4 27.4 1.0
O A:HOH4262 4.4 37.7 1.0
N A:4HZ4000 4.7 24.1 1.0
C A:GLY856 4.9 34.9 1.0
C A:4HZ4000 4.9 28.3 1.0
OD2 A:ASP939 4.9 29.2 1.0

Fluorine binding site 2 out of 4 in 4ytf

Go back to Fluorine Binding Sites List in 4ytf
Fluorine binding site 2 out of 4 in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F4000

b:26.9
occ:1.00
 F2 A:4HZ4000 0.0 26.9 1.0
C4 A:4HZ4000 1.3 26.8 1.0
F1 A:4HZ4000 2.1 31.1 1.0
F A:4HZ4000 2.1 26.9 1.0
C3 A:4HZ4000 2.3 24.0 1.0
N A:4HZ4000 2.9 24.1 1.0
CD2 A:LEU983 3.1 21.6 1.0
O A:ARG980 3.1 17.0 1.0
CG A:LEU983 3.4 18.2 1.0
O A:HOH4120 3.6 22.7 1.0
C2 A:4HZ4000 3.9 27.3 1.0
CB A:SER936 4.0 18.7 1.0
O A:ILE982 4.0 17.4 1.0
C A:ARG980 4.2 18.4 1.0
CA A:ASN981 4.2 13.5 1.0
C A:ASN981 4.2 18.3 1.0
N3 A:4HZ4000 4.3 19.7 1.0
CD1 A:LEU983 4.3 17.1 1.0
C A:ILE982 4.3 17.8 1.0
N A:ILE982 4.3 13.8 1.0
O A:4HZ4000 4.3 31.1 1.0
CA A:SER936 4.5 15.8 1.0
C8 A:4HZ4000 4.6 20.5 1.0
C5 A:4HZ4000 4.6 23.3 1.0
CB A:LEU983 4.6 14.2 1.0
N A:ASN981 4.6 14.2 1.0
N A:LEU983 4.6 13.8 1.0
O A:ASN981 4.7 18.1 1.0
C13 A:4HZ4000 4.7 18.4 1.0
CA A:LEU983 4.7 13.8 1.0
C9 A:4HZ4000 4.8 18.5 1.0
C12 A:4HZ4000 4.9 17.5 1.0
N1 A:4HZ4000 4.9 23.6 1.0
CA A:ILE982 4.9 13.6 1.0
OD1 A:ASN981 5.0 20.6 1.0

Fluorine binding site 3 out of 4 in 4ytf

Go back to Fluorine Binding Sites List in 4ytf
Fluorine binding site 3 out of 4 in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F4000

b:31.1
occ:1.00
 F1 A:4HZ4000 0.0 31.1 1.0
C4 A:4HZ4000 1.3 26.8 1.0
F2 A:4HZ4000 2.1 26.9 1.0
F A:4HZ4000 2.1 26.9 1.0
C3 A:4HZ4000 2.4 24.0 1.0
C A:ASN981 3.1 18.3 1.0
O A:ASN981 3.1 18.1 1.0
CA A:ASN981 3.3 13.5 1.0
CA A:GLY993 3.3 17.6 1.0
C A:GLY993 3.6 23.0 1.0
N A:4HZ4000 3.6 24.1 1.0
N A:ILE982 3.7 13.8 1.0
CG A:LEU983 3.7 18.2 1.0
N A:GLY993 3.8 15.6 1.0
N A:ASP994 3.8 20.0 1.0
O A:ARG980 3.9 17.0 1.0
CD1 A:LEU983 4.1 17.1 1.0
CB A:ASN981 4.2 15.1 1.0
CD2 A:LEU983 4.2 21.6 1.0
OD1 A:ASN981 4.3 20.6 1.0
C A:ILE982 4.3 17.8 1.0
O A:GLY993 4.3 23.7 1.0
N A:ASN981 4.3 14.2 1.0
CA A:ILE982 4.3 13.6 1.0
O A:4HZ4000 4.4 31.1 1.0
CB A:ASP994 4.5 22.8 1.0
C2 A:4HZ4000 4.5 27.3 1.0
C A:ARG980 4.5 18.4 1.0
N A:LEU983 4.5 13.8 1.0
O A:ILE982 4.6 17.4 1.0
CG A:ASN981 4.7 29.0 1.0
CA A:ASP994 4.8 20.4 1.0
CB A:LEU983 4.8 14.2 1.0
C A:ILE992 5.0 17.3 0.5
C A:ILE992 5.0 18.0 0.5

Fluorine binding site 4 out of 4 in 4ytf

Go back to Fluorine Binding Sites List in 4ytf
Fluorine binding site 4 out of 4 in the Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase (Jak) 3 Inhibitor For the Treatment of Autoimmune Diseases within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F4000

b:26.9
occ:1.00
 F A:4HZ4000 0.0 26.9 1.0
C4 A:4HZ4000 1.3 26.8 1.0
F1 A:4HZ4000 2.1 31.1 1.0
F2 A:4HZ4000 2.1 26.9 1.0
C3 A:4HZ4000 2.4 24.0 1.0
N A:4HZ4000 2.9 24.1 1.0
O A:4HZ4000 3.0 31.1 1.0
C2 A:4HZ4000 3.2 27.3 1.0
CD1 A:LEU983 3.4 17.1 1.0
CG A:LEU983 3.4 18.2 1.0
CD2 A:LEU983 3.4 21.6 1.0
C13 A:4HZ4000 3.5 18.4 1.0
C14 A:4HZ4000 3.9 19.8 1.0
CL A:4HZ4000 4.1 22.4 1.0
C12 A:4HZ4000 4.2 17.5 1.0
N3 A:4HZ4000 4.2 19.7 1.0
CA A:GLY993 4.4 17.6 1.0
C1 A:4HZ4000 4.5 25.6 1.0
N A:ASP994 4.5 20.0 1.0
O A:HOH4225 4.5 41.9 1.0
C9 A:4HZ4000 4.8 18.5 1.0
C8 A:4HZ4000 4.8 20.5 1.0
C A:GLY993 4.8 23.0 1.0
CB A:LEU983 4.8 14.2 1.0
C15 A:4HZ4000 4.9 17.2 1.0
C5 A:4HZ4000 4.9 23.3 1.0
O A:ARG980 4.9 17.0 1.0

Reference:

L.J.Farmer, M.W.Ledeboer, T.Hoock, M.J.Arnost, R.S.Bethiel, Y.L.Bennani, J.J.Black, C.L.Brummel, A.Chakilam, W.A.Dorsch, B.Fan, J.E.Cochran, S.Halas, E.M.Harrington, J.K.Hogan, D.Howe, H.Huang, D.H.Jacobs, L.M.Laitinen, S.Liao, S.Mahajan, V.Marone, G.Martinez-Botella, P.Mccarthy, D.Messersmith, M.Namchuk, L.Oh, M.S.Penney, A.C.Pierce, S.A.Raybuck, A.Rugg, F.G.Salituro, K.Saxena, D.Shannon, D.Shlyakter, L.Swenson, S.K.Tian, C.Town, J.Wang, T.Wang, M.W.Wannamaker, R.J.Winquist, H.J.Zuccola. Discovery of Vx-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor For the Treatment of Autoimmune Diseases. J.Med.Chem. V. 58 7195 2015.
ISSN: ISSN 0022-2623
PubMed: 26230873
DOI: 10.1021/ACS.JMEDCHEM.5B00301
Page generated: Tue Jul 15 01:46:10 2025

Last articles

Fe in 9JP5
Fe in 9K2G
Fe in 9K36
Fe in 9JN8
Fe in 9JPI
Fe in 9JN5
Fe in 9JN4
Fe in 9JIP
Fe in 9JI6
Fe in 9JI1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy